Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Pneumococcal Disease Vaccines
Research in the area of pneumococcal disease vaccines reported from Chongqing Medical University
April 8th, 2009
New investigation results, 'Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection,' are detailed in a study published in Clinical & Experimental Immunology. "Invasive pneumococcal diseases incur significant mortality, morbidity and economic costs. The most effective strategy currently available to reduce the burden of these diseases is vaccination," scientists writing in the journal Clinical & Experimental Immunology report. "In this study, we evaluated the protective efficacy of immunizing mice with caseinolytic protease (ClpP) protein antigen whose gene sequences were shown to...
Source: Vaccine Weekly (2009-04-08)
|
